Loading...
Publication
Molecular determinants of the response to malaria therapeutics
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.14 MB | Adobe PDF | |||
| 79.31 KB | Adobe PDF | |||
| 67.91 KB | Adobe PDF | |||
| 200.05 KB | Adobe PDF | |||
| 66.38 KB | Adobe PDF |
Authors
Abstract(s)
The overall aim of this thesis was the analysis of the genetic variability in genes
coding for proteins important in drug metabolism. The analysis of the metabolism of
antimalarial drugs, particularly amodiaquine, and the possible contribution of
biotransformation for the susceptibility to the disease was also studied.
The results obtained in the genotyping studies in the populations of Guinea-
Bissau, Portugal, Sao Tome and Principe, Thailand and Zanzibar showed a high
interethnic variability. A high variability in Africans was observed. The study of the
effect of CYP2C8 genotype in the AQ treatment outcome revealed that none of the
alleles analysed influence therapeutic efficacy.
In the analysis of amodiaquine metabolism we focused particularly on the
metabolite desethylamodiaquine. Using microsomes enriched with recombinant CYPs,
a reduction in drug concentration was observed in the presence of CYP1A1. The
posterior investigation of the genetic variation in CYP1A1 identified several SNPs,
particularly in the Papua New Guinea population. However, this variability could not
be associated with the extreme variability observed in pharmacokinetic parameters.
The study on the influence of the GSTT1 null genotype in uncomplicated
malaria revealed that the lack of this gene seems to be a protective factor in this
disease
Description
Tese dout., Bioquímica, Universidade do Algarve, 2007
Keywords
Teses Biologia celular Biologia molecular Farmacologia Genética